FPH Stock Overview
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 4/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
FPH passed our risk checks.
Fisher & Paykel Healthcare Corporation Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NZ$25.65 |
52 Week High | NZ$27.95 |
52 Week Low | NZ$20.29 |
Beta | 0.41 |
1 Month Change | 2.19% |
3 Month Change | 8.69% |
1 Year Change | -3.75% |
3 Year Change | -19.16% |
5 Year Change | 66.56% |
Change since IPO | 5,600.00% |
Recent News & Updates
Is Fisher & Paykel Healthcare (NZSE:FPH) Using Too Much Debt?
Mar 27Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
Feb 22Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Business Is Yet to Catch Up With Its Share Price
Feb 05Recent updates
Is Fisher & Paykel Healthcare (NZSE:FPH) Using Too Much Debt?
Mar 27Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
Feb 22Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Business Is Yet to Catch Up With Its Share Price
Feb 05Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares Could Be 31% Above Their Intrinsic Value Estimate
Jan 03We Think Fisher & Paykel Healthcare (NZSE:FPH) Can Stay On Top Of Its Debt
Nov 30Fisher & Paykel Healthcare (NZSE:FPH) Could Be Struggling To Allocate Capital
Nov 12Estimating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Aug 28Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
Aug 10Here's Why Fisher & Paykel Healthcare (NZSE:FPH) Can Manage Its Debt Responsibly
Jul 02Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
May 01Returns On Capital Signal Tricky Times Ahead For Fisher & Paykel Healthcare (NZSE:FPH)
Jan 23Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?
Dec 27Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Oct 28Shareholders Are Optimistic That Fisher & Paykel Healthcare (NZSE:FPH) Will Multiply In Value
Oct 13Fisher & Paykel Healthcare (NZSE:FPH) Has A Pretty Healthy Balance Sheet
Sep 28Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Jul 24A Look Into Fisher & Paykel Healthcare's (NZSE:FPH) Impressive Returns On Capital
Jul 10Fisher & Paykel Healthcare (NZSE:FPH) Seems To Use Debt Quite Sensibly
Jun 12A Look At The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Apr 17Fisher & Paykel Healthcare (NZSE:FPH) Could Become A Multi-Bagger
Apr 04Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?
Mar 06With EPS Growth And More, Fisher & Paykel Healthcare (NZSE:FPH) Is Interesting
Jan 22Why The 41% Return On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Should Have Your Attention
Dec 26Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Dec 05This Is The Reason Why We Think Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Deserves A Bump Up To Their Compensation
Aug 11Is Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Worth NZ$31.6 Based On Its Intrinsic Value?
Aug 01Do Fisher & Paykel Healthcare's (NZSE:FPH) Earnings Warrant Your Attention?
Jul 07Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Jun 24A Look Into Fisher & Paykel Healthcare's (NZSE:FPH) Impressive Returns On Capital
May 01Here's Why We Think Fisher & Paykel Healthcare (NZSE:FPH) Is Well Worth Watching
Mar 28Is Fisher & Paykel Healthcare (NZSE:FPH) Using Too Much Debt?
Mar 16Have Insiders Been Selling Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares?
Mar 04How Much Is Fisher & Paykel Healthcare's (NZSE:FPH) CEO Getting Paid?
Feb 20Is Weakness In Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Feb 05Are Investors Overlooking Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH)?
Jan 25Did You Participate In Any Of Fisher & Paykel Healthcare's (NZSE:FPH) Incredible 325% Return?
Jan 14Here's What Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Shareholder Ownership Structure Looks Like
Jan 03Should You Be Adding Fisher & Paykel Healthcare (NZSE:FPH) To Your Watchlist Today?
Dec 24Shareholder Returns
FPH | NZ Medical Equipment | NZ Market | |
---|---|---|---|
7D | -1.5% | 3.0% | 1.4% |
1Y | -3.8% | 16.1% | -3.1% |
Return vs Industry: FPH underperformed the NZ Medical Equipment industry which returned 16.1% over the past year.
Return vs Market: FPH matched the NZ Market which returned -3.1% over the past year.
Price Volatility
FPH volatility | |
---|---|
FPH Average Weekly Movement | 3.3% |
Medical Equipment Industry Average Movement | 11.2% |
Market Average Movement | 4.1% |
10% most volatile stocks in NZ Market | 7.3% |
10% least volatile stocks in NZ Market | 2.4% |
Stable Share Price: FPH has not had significant price volatility in the past 3 months.
Volatility Over Time: FPH's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1934 | 6,420 | Lewis Gradon | https://www.fphcare.com |
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation.
Fisher & Paykel Healthcare Corporation Limited Fundamentals Summary
FPH fundamental statistics | |
---|---|
Market cap | NZ$14.98b |
Earnings (TTM) | NZ$261.70m |
Revenue (TTM) | NZ$1.69b |
57.2x
P/E Ratio8.8x
P/S RatioIs FPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
FPH income statement (TTM) | |
---|---|
Revenue | NZ$1.69b |
Cost of Revenue | NZ$682.90m |
Gross Profit | NZ$1.01b |
Other Expenses | NZ$749.60m |
Earnings | NZ$261.70m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
May 29, 2024
Earnings per share (EPS) | 0.45 |
Gross Margin | 59.69% |
Net Profit Margin | 15.45% |
Debt/Equity Ratio | 13.9% |
How did FPH perform over the long term?
See historical performance and comparison